Parallax Volatility Advisers’s Abiomed Inc ABMD Stock Holding History

Parallax Volatility Advisers’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,500	Closed	-$497K	–	3471
2022 Q1	$497K	Buy	+1,500	New	+$462K	﹤0.01%	1907
2021 Q3	–	Sell	-100	Closed	-$31K	–	3583
2021 Q2	$31K	Buy	+100	New	+$30.7K	﹤0.01%	2697
2021 Q1	–	Sell	-16,000	Closed	-$5.18M	–	3779
2020 Q4	$5.18M	Sell	16,000 -32,900	-67%	-$9.1M	﹤0.01%	1427
2020 Q3	$13.5M	Buy	48,900 +14,700	+43%	+$4.23M	0.01%	865
2020 Q2	$8.26M	Buy	34,200 +22,000	+180%	+$4.42M	0.01%	880
2020 Q1	$1.78M	Buy	+12,200	New	+$2.03M	﹤0.01%	1282
2018 Q4	–	Sell	-15,000	Closed	-$6.75M	–	4244
2018 Q3	$6.75M	Buy	+15,000	New	+$5.91M	0.01%	609
2016 Q1	–	Sell	-10,000	Closed	-$903K	–	3971
2015 Q4	$903K	Buy	+10,000	New	+$849K	﹤0.01%	1319

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Parallax Volatility Advisers's ABMD Position: Q3 2021 in Review

Parallax Volatility Advisers sold out of Abiomed Inc (ABMD) in Q3 2021, closing a stake of 61 shares — an estimated $20.7K sold.

Parallax Volatility Advisers first reported a position in ABMD in Q2 2018 and held it in 10 quarters. The position peaked at $5.09M in Q1 2019. 498 funds tracked by Wall St. Rank hold ABMD as of Q3 2021.

Parallax Volatility Advisers reported no remaining Abiomed Inc position as of Q3 2021 after selling out during the quarter.
Parallax Volatility Advisers sold 61 Abiomed Inc shares in Q3 2021, an estimated $20.7K.
Parallax Volatility Advisers first reported a position in Abiomed Inc in Q2 2018 and held it in 10 quarters.
Parallax Volatility Advisers's Abiomed Inc position peaked at $5.09M in Q1 2019.
498 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2021.

Based on Parallax Volatility Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.